Ozoralizumab Completed Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01063803Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis